Global Neurological Biomarkers market will reach 8950 million US$ by the end of 2025

Publisher: QYResearch
Published Date: 2019/8/13

The market will witness significant growth in the forthcoming years because of existing neurological disorders cases among patients across the world. Neurological biomarkers are indicators for measuring pathological and physiological processes to determine therapeutic intervention. Neuropathologists are extensively using these biomarkers for making an accurate diagnosis. Rising research and development activities due to increasing incidences of neurological disorders in a large population base are expected to boost the market.

Biomarkers are used for patients who are suffering from acute ischemic stroke, subarachnoid hemorrhage, traumatic brain injury, and intracerebral hemorrhage. The recovery from such diseases such as neurocritical diseases and crucial diseases is mainly dependent on the condition of the patient. Such type of diseases may get delayed for proper examining of the patients because of certain complexities. To measure these problems, there has been a need for biomarkers, which, in turn, is expected to drives the growth of the market.

As per the report, the global neurological biomarkers market is expected to touch the valuation at US$8950 mn by the end of 2025 from US$4710 mn in the year 2018. The market is likely to register a CAGR of 9.6% throughout the anticipated period.

Click to view the full report:  https://www.qyresearch.com/index/detail/1076292/global-neurological-biomarkers-market
This article was first released by QYResearch, if reproduced, please indicate the source.
Telephone number:020-22093278
Contact:holly@qyresearch.com
When contacting, please refer to QYR company's Mia introduction.